Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

Clinical trial NCT07020832 · SUSPENDED

Trial details

NCT number: NCT07020832
Sponsor: Apellis Pharmaceuticals, Inc.
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Delayed Graft Function End Stage Renal Disease Deceased Donor Kidney Transplant

Start date: 2026-05-18
Primary completion: 2029-06-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.